Taken together, alterations of AR affected by androgen-deprivation could change prostate cancer cell metabolism via multiple intra- and extra-cellular signaling pathways, smsDX effects on the cancer cell metabolism regulating energy, lipid, amino acid and protein biosynthesis provide in-depth information to improve the response to therapy and result in a positive clinical outcomes. This evidence concerns the gene AR and Familial prostate cancer.